This funding will enable us to finish last testing of the procedure in animal models of XLRS in addition to complete the pre-clinical safety studies required by the FDA in order to start a Phase 1 human being clinical trial. The ultimate goal is to improve these patients’ standard of living; there happens to be no treatment available for the a large number of young males losing their sight because of XLRS. .. AGTC receives FFB grant to evaluate gene therapy treatment for X-linked Retinoschisis Applied Genetic Technologies Company, a privately-held, clinical stage biotechnology company developing novel systems to provide individual therapeutics, announces that it offers received a grant of $1.MIs can occur without common symptoms in women . They could sense shoulder discomfort of chest pain instead, they might think they have severe flu that is taken quite a long time to recover from, and those with an inferior-wall structure infarction might complain of belly pain. So women may hold back from reporting symptoms and doctors may also be in question whether to consider cardiovascular disease as a source of the issues. Dr Boersma says another issue is that ladies and their doctors possess typically worried more about loss of life from breasts and gynaecological cancers, than from cardiovascular disease.